See also this year's filing and all EDGAR filings for this company.
PDF Report 0001302573_2019_Oncomed_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001302573, Oncomed Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 63,727,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 623,000 |
| 3 | remainder_Assets | 728,000 |
| 4 | LiabilitiesCurrent | 12,644,000 |
| 5 | LiabilitiesNoncurrent | 100,000 |
| 6 | remainder_Liabilities | 4,103,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,514,447 |
| 9 | ResearchAndDevelopmentExpense | 18,105,150 |
| 10 | remainder_Expenses | 1,460,427 |
| 11 | remainder_Revenues | 46,675,648 |
| 12 | remainder_NetIncome | 618,223 |
| 13 | remainder_ComprehensiveNetIncome | -610,159 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 65,078,000 |
| 1 | Liabilities | 16,847,000 |
| 2 | Expenses | 38,080,024 |
| 3 | Revenues | 46,675,648 |
| 4 | StockholdersEquity | 48,231,000 |
| 5 | NetIncome | 9,213,847 |
| 6 | ComprehensiveNetIncome | 8,908,768 |
| 7 | BaseVar | 83,954,527 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.78 |
| 9 | EconomicCapitalRatio | 3.54 |
Edgar->Model Mapping
Feature Distribution
Change over Time
